Florent Grange

Florent Grange

Clermont-ferrand, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 111 publications

Durable remission with no survival reduction after mogamulizumab discontinuation in Sézary syndrome.

Durable remission with no survival reduction after mogamulizumab discontinuation in Sézary syndrome.

Journal: The British journal of dermatology

Published: March 13, 2026

CYLD Cutaneous Syndrome: Report of a New Splicing Pathogenic Variant and Additional Evidence Supporting the Absence of Genotype-Phenotype Correlation.

CYLD Cutaneous Syndrome: Report of a New Splicing Pathogenic Variant and Additional Evidence Supporting the Absence of Genotype-Phenotype Correlation.

Journal: International journal of dermatology

Published: December 15, 2025

Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.

Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 22, 2025

Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS).

Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS).

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 22, 2025

Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score-Matched Controlled Prospective Study.

Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score-Matched Controlled Prospective Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 13, 2025

Integrated histomolecular approach to discriminate primary cutaneous follicle centre and marginal zone lymphoma of the scalp.

Integrated histomolecular approach to discriminate primary cutaneous follicle centre and marginal zone lymphoma of the scalp.

Journal: Pathology

Published: January 15, 2025

Erratum: Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study.

Erratum: Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study.

Journal: EClinicalMedicine

Published: December 25, 2024

Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: a nationwide real-life study in France (NEOMEL).

Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: a nationwide real-life study in France (NEOMEL).

Journal: The British journal of dermatology

Published: December 10, 2024

Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in patients with advanced melanoma with BRAFV600E or BRAFV600K mutations (EBIN): an international, open-label, randomised, controlled, phase 2 study.

Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in patients with advanced melanoma with BRAFV600E or BRAFV600K mutations (EBIN): an international, open-label, randomised, controlled, phase 2 study.

Journal: The Lancet. Oncology

Published: October 23, 2024

Recurrent primary cutaneous marginal zone lymphoma: a comparative study of initial tumours, recurrences, and outcomes in 61 patients.

Recurrent primary cutaneous marginal zone lymphoma: a comparative study of initial tumours, recurrences, and outcomes in 61 patients.

Journal: Histopathology

Published: August 10, 2024

Benefit of immune checkpoint inhibitors as adjuvant treatment for acral melanomas.

Benefit of immune checkpoint inhibitors as adjuvant treatment for acral melanomas.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: April 11, 2024

Impact of the COVID-19 pandemic on melanoma: A retrospective study from the French clinical database of melanoma patients (RIC-Mel).

Impact of the COVID-19 pandemic on melanoma: A retrospective study from the French clinical database of melanoma patients (RIC-Mel).

Journal: Annales de dermatologie et de venereologie

Published: February 22, 2024

Showing 1-12 of 111

Last Updated: 09/26/2026